Keep pulling the thread on Shiv Rao.
Abridge's platform has been shown to reduce clinician cognitive burden by 60% within six weeks of use.
Abridge is currently deployed in over 110 health systems.
Abridge's primary competitor in head-to-head sales deals with large health systems is Microsoft.
Abridge recently secured a $250 million Series D fundraising round.
According to Shiv Rao, 40% of doctors (two out of five) are considering leaving the medical profession in the next two to three years.
Abridge is processing millions of medical conversations every couple of days.
Abridge's future roadmap includes providing real-time clinical decision support and identifying patients eligible for clinical trials during conversations.
Based on a survey from Stanford University, Abridge's technology has reduced clinician burnout by 50% within the first two months of use.
Abridge recently announced a partnership with Memorial Sloan Kettering Cancer Center.
A JAMA article published in 2023 found that 27% of nurses intend to leave the profession within the next 12 months.
Abridge has raised over $500 million in total funding.
Abridge claims to have never lost a head-to-head sales competition against Microsoft in recent years.